- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ePhysician nets $18 million from investors in third round
Wireless e-health company ePhysician has closed its third round of funding, pocketing $18 million from a private investment group. The privately held company plans to use the additional funds to expand ePhysician's suite of clinical
Wireless e-health company ePhysician has closed its third round of funding, pocketing $18 million from a private investment group. The privately held company plans to use the additional funds to expand ePhysician's suite of clinical applications and to increase sales and marketing to its target market (physicians). ePhysician claims 8000 users and more than 400,000 prescriptions sent using its software. The application suite enables doctors to transmit electronic prescriptions securely over the Internet, to capture diagnosis and billing information, and to access drug reference information. The investors included Dresdner Kleinwort Capital (which led the group), Benchmark Capital, CVS, and Palm Ventures.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
